Modified ribonucleases
    1.
    发明授权
    Modified ribonucleases 有权
    修饰的核糖核酸酶

    公开(公告)号:US08840882B2

    公开(公告)日:2014-09-23

    申请号:US11823334

    申请日:2007-06-25

    IPC分类号: A61K38/46 C12N9/22

    CPC分类号: C12N9/22 A61K38/00 C12N9/96

    摘要: The present invention relates generally to conjugates of human ribonucleases and water-soluble polymers, compositions comprising the conjugates and methods of using the same. In particular, the present invention provides conjugates of human ribonucleases and one or more water-soluble polymer compositions (e.g., to increase serum half-life and a pharmacokinetic profile, in vivo biological activity, stability, and/or reduce host immune response to the protein in vivo) as well as methods of using the conjugates in the therapy, treatment, and/or prevention of disease (e.g., cancer).

    摘要翻译: 本发明一般涉及人核糖核酸酶和水溶性聚合物的缀合物,包含缀合物的组合物及其使用方法。 特别地,本发明提供人核糖核酸酶和一种或多种水溶性聚合物组合物的缀合物(例如,以增加血清半衰期和药代动力学特征,体内生物活性,稳定性和/或降低对 体内的蛋白质)以及在治疗,治疗和/或预防疾病(例如癌症)中使用缀合物的方法。

    Compositions and methods for ribonuclease-based therapeutics
    5.
    发明授权
    Compositions and methods for ribonuclease-based therapeutics 失效
    用于核糖核酸酶的治疗剂的组合物和方法

    公开(公告)号:US08697062B2

    公开(公告)日:2014-04-15

    申请号:US12247438

    申请日:2008-10-08

    IPC分类号: A61K38/46 C12N9/22 C07H21/04

    摘要: The present invention relates generally to conjugates of human ribonucleases and water-soluble polymers, compositions comprising the conjugates and methods of using the same. In particular, the present invention provides conjugates of human ribonucleases and one or more water-soluble polymer compositions (e.g., to increase serum half-life and a pharmacokinetic profile, in vivo biological activity, stability, and/or reduce host immune response to the protein in vivo) as well as methods of using the conjugates in the therapy, treatment, and/or prevention of disease (e.g., cancer).

    摘要翻译: 本发明一般涉及人核糖核酸酶和水溶性聚合物的缀合物,包含缀合物的组合物及其使用方法。 特别地,本发明提供人核糖核酸酶和一种或多种水溶性聚合物组合物的缀合物(例如,以增加血清半衰期和药代动力学特征,体内生物活性,稳定性和/或降低对 体内的蛋白质)以及在治疗,治疗和/或预防疾病(例如癌症)中使用缀合物的方法。

    COMPOSITIONS AND METHODS FOR RIBONUCLEASE-BASED THERAPEUTICS
    7.
    发明申请
    COMPOSITIONS AND METHODS FOR RIBONUCLEASE-BASED THERAPEUTICS 失效
    用于基于核糖核酸酶的治疗剂的组合物和方法

    公开(公告)号:US20090098101A1

    公开(公告)日:2009-04-16

    申请号:US12247438

    申请日:2008-10-08

    IPC分类号: A61K38/46 C12N9/22 A61P35/00

    摘要: The present invention relates generally to conjugates of human ribonucleases and water-soluble polymers, compositions comprising the conjugates and methods of using the same. In particular, the present invention provides conjugates of human ribonucleases and one or more water-soluble polymer compositions (e.g., to increase serum half-life and a pharmacokinetic profile, in vivo biological activity, stability, and/or reduce host immune response to the protein in vivo) as well as methods of using the conjugates in the therapy, treatment, and/or prevention of disease (e.g., cancer).

    摘要翻译: 本发明一般涉及人核糖核酸酶和水溶性聚合物的缀合物,包含缀合物的组合物及其使用方法。 特别地,本发明提供人核糖核酸酶和一种或多种水溶性聚合物组合物的缀合物(例如,以增加血清半衰期和药代动力学特征,体内生物活性,稳定性和/或降低对 体内的蛋白质)以及在治疗,治疗和/或预防疾病(例如癌症)中使用缀合物的方法。